CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Calcipotriene And Betamethasone Dipropionate patents expire, and what generic alternatives are available?
Calcipotriene And Betamethasone Dipropionate is a drug marketed by Glenmark Pharms Ltd, Chartwell Rx, Padagis Israel, Cosette, and Taro. and is included in five NDAs.
The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
- What are the global sales for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
- What is Average Wholesale Price for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
Summary for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 16 |
Patent Applications: | 66 |
What excipients (inactive ingredients) are in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE? | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE excipients list |
DailyMed Link: | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Phase 4 |
Eli Lilly and Company | Phase 4 |
Celgene Corporation | Phase 4 |
See all CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE clinical trials
Pharmacology for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Drug Class | Corticosteroid Vitamin D Analog |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |